Tudor Investment Corp
RCKT icon

Tudor Investment Corp’s Rocket Pharmaceuticals RCKT Stock Holding History

Tudor Investment Corp’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$181K Buy
50,493
+8,082
+19% +$32.1K ﹤0.01% 3394
2025
Q4 		$149K Sell
42,411
-7,696
-15% -$26.4K ﹤0.01% 3344
2025
Q3 		$163K Sell
50,107
-66
-0.1% -$208 ﹤0.01% 3228
2025
Q2 		$123K Buy
50,173
+36
+0.1% +$182 ﹤0.01% 3145
2025
Q1 		$334K Buy
50,137
+19,012
+61% +$188K ﹤0.01% 2526
2024
Q4 		$391K Buy
31,125
+14,338
+85% +$216K ﹤0.01% 2402
2024
Q3 		$310K Buy
+16,787
New +$344K ﹤0.01% 2302
2023
Q3 		– Sell
-22,873
Closed -$454K – 2874
2023
Q2 		$454K Buy
+22,873
New +$462K 0.01% 1766
2022
Q2 		– Sell
-32,787
Closed -$520K – 2539
2022
Q1 		$520K Buy
+32,787
New +$566K 0.01% 1256

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return